IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.770
-0.060 (-3.28%)
Jan 17, 2025, 4:00 PM EST - Market closed
IGM Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for IGM Biosciences stock have an average target of 6.14, with a low estimate of 1.50 and a high estimate of 22. The average target predicts an increase of 246.89% from the current stock price of 1.77.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IGMS stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Buy | 2 | 2 | 2 | 2 | 3 | 1 |
| Hold | 4 | 4 | 4 | 4 | 3 | 7 |
| Sell | 0 | 0 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Jan 13, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $48 → $2 | Strong Buy → Hold | Downgrades | $48 → $2 | +12.99% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $12 → $2 | Hold | Maintains | $12 → $2 | +12.99% | Jan 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $27 → $2.5 | Strong Buy → Hold | Downgrades | $27 → $2.5 | +41.24% | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $20 → $1.5 | Buy → Hold | Downgrades | $20 → $1.5 | -15.25% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
2.63M
from 2.13M
Increased by 23.57%
Revenue Next Year
7.70M
from 2.63M
Increased by 192.36%
EPS This Year
-3.41
from -4.71
EPS Next Year
-2.31
from -3.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.2M | 24.8M | 43.8M | |||
| Avg | 2.6M | 7.7M | 13.1M | |||
| Low | 2.2M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 47.9% | 843.4% | 469.7% | |||
| Avg | 23.6% | 192.4% | 69.7% | |||
| Low | 4.3% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.77 | -1.52 | -1.35 | |||
| Avg | -3.41 | -2.31 | -2.06 | |||
| Low | -3.59 | -3.90 | -3.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.